Tokyo, October 01, 2020: Eisai Co., Ltd. and Seikagaku Corporation announced today that the companies have entered into an agreement…
Tokyo, September 23, 2020: Eisai Co., Ltd. announced that it has received a positive opinion from the European Medicines Agency…
Tokyo, September 18, 2020: Eisai Co., Ltd. has announced that the latest results from the cohort targeting patients with HER2-negative…
Tokyo, September 17, 2020: Eisai Co., Ltd. announced today that it has established a new pharmaceutical sales subsidiary in Ho…
Tokyo, July 15, 2020: - (JCN Newswire) - Eisai Co., Ltd. announced today that it has entered into an industry-academia-government…
New Delhi, July 14, 2020: The Alzheimer's Clinical Trials Consortium (ACTC), Eisai Co., Ltd., and Biogen Inc. announced today that…
Tokyo, June 04, 2020: Eisai Co., Ltd. announced today that its U.S. subsidiary Eisai Inc. has launched its in-house discovered…
TOKYO, September 29, 2019: (JCN Newswire) - Eisai Co., Ltd. and FRONTEO, Inc. announced today that they have launched the…
TECERIS® aimed at expanding access to metastatic breast cancer patients in India Vishakhapatnam, September 29, 2019: Eisai Pharmaceuticals India Pvt.…
Tokyo, September 29, 2019: Eisai Co., Ltd. announced today that a series of abstracts will be presented during the European…